financetom
Personal Finance
financetom
/
Personal Finance
/
TATA AIG launches 'Health Supercharge' with sum insured ranging from ₹5 lakh to ₹20 lakh
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TATA AIG launches 'Health Supercharge' with sum insured ranging from ₹5 lakh to ₹20 lakh
Nov 29, 2023 9:31 AM

TATA AIG General Insurance Company has launched “Health Supercharge” with a sum insured ranging from ₹5 lakh to ₹20 lakh. Customers can choose from options of two plan variants (Value Plan and Geo Plan), basis their geographical location, and other optional benefits offered under the product as per one’s requirement.

Live TV

Loading...

Speaking about the new health insurance policy – TATA AIG Health Supercharge, Santosh Puri, Senior Vice President – Health Product & Process, TATA AIG General Insurance said, “With the launch of Health Supercharge, we will be able to provide policyholders with 5X more coverage for their well-being."

Key highlights of Tata AIG Health Supercharge include:

The product introduces an enhanced level of coverage through a 5X supercharge bonus. This policy offers on each renewal a bonus of 50% of base sum insured of the expiring policy and accumulating maximum bonus up to 500% of the base sum insured in any policy year irrespective of claims.

Families below the age of 40 years or below at the time of first policy inception can benefit from an extra 5% discount which is also applicable upon policy renewals, irrespective of claims, the insurance company said.

The policy offers tailored flexibility with two plan variants (Value Plan & Geo Plan), and optional benefits such as unlimited restore, reduction of Pre-Existing Disease (PED) waiting period for named ailments.

Preventive annual health check-up can be availed by the insured persons once in a policy year, irrespective of claims, by paying an additional premium.

(Edited by : Anshul)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Marvell Technology, Inc.
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Marvell Technology, Inc.
May 30, 2024
12:50 AM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target at $94 on P/E of 37.6x our CY 25 EPS view, above peers given our view of trough fundamentals. We adjust our FY 25 (Jan.)...
Stock Market Today: Salesforce Earnings Drag Dow Down 330 Points
Stock Market Today: Salesforce Earnings Drag Dow Down 330 Points
May 30, 2024
Stocks closed lower Thursday as investors took in a number of disappointing corporate earnings reports and looked ahead to tomorrow's key inflation update.  The Dow Jones Industrial Average suffered a notable loss today as Salesforce ( CRM ) crumbled after earnings, but the blue chip stock was hardly the day's biggest loser.    To be sure, CRM's 19.7% tumble was...
Research Alert: CFRA Maintains Buy Opinion On Adss Of Telecom Italia S.p.a.
Research Alert: CFRA Maintains Buy Opinion On Adss Of Telecom Italia S.p.a.
May 31, 2024
04:30 AM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We retain our Buy recommendation on Telecom Italia (TIT), with the same target price of USD3.50. This represents a 2024 EV/EBITDA of 6.2x, a premium to its long-term average multiples...
Research Alert: CFRA Maintains Sell Opinion On Shares Of The Gap, Inc.
Research Alert: CFRA Maintains Sell Opinion On Shares Of The Gap, Inc.
May 31, 2024
07:55 AM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by $5 to $20, based on 12.5x our FY 25 (Jan.) EPS estimate and below the company's 1-year average forward P/E multiple of 15.0x,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved